| Drug Type Autologous CAR-T | 
| Synonyms B7H3 specific CAR T cell with IL-7Ra signaling domain, B7H3 With IL-7 Receptor Alpha Signaling Chimeric Antigen Receptor T Cell, CDM03 CAR T Cell(University of Chulalongkorn) | 
| Target | 
| Action modulators | 
| Mechanism CD276 modulators(CD276 antigen modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Relapsed Solid Neoplasm | Phase 1 | Thailand  | 01 Apr 2025 | |
| Diffuse Intrinsic Pontine Glioma | Phase 1 | Thailand  | 01 Mar 2024 | 





